Stockreport

H.C. Wainwright Reaffirms Buy Rating for Legend Biotech (LEGN) [Yahoo! Finance]

Legend Biotech Corporation - American Depositary Shares  (LEGN) 
PDF Wainwright maintained its Buy rating for Legend Biotech Corp. (NASDAQ:LEGN). The firm has projected a target price of $50, which yields more than 109% potential upside f [Read more]